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Abstract 
Cancer registry is a growing field and with data being collected year round the 
data needs to be of good quality standing. Quality of cancer care is measurable per 
standards when met within the time frame allotted per care regimen. Cancer programs 
are evaluating and implementing new process to make their data valid and complete 
through information technology and connection among hospital-based and community-
based practices. The aim of this study is to review the available validity, barriers and 
utilization related to quality of cancer care data. The studies were consistent among 
each other in that a concurrent review of data, real-time collection, will be valid to the 
standards in cancer care. Rapid Quality Reporting System is still in its prime stage and 
the studies have concluded that using the reporting tool is best.  
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Quality of Cancer Registry Data 
Chapter 1 
Introduction 
Improving the quality of care requires useful measures of quality, the availability 
of data, defined mechanism to utilize the data and commitment of providers and 
institutions. The quality of the care provided is ranked or scored from national 
standards, indicators and policies that each health professionals follows in their normal 
day of work.  
The definition of quality described by Institute of Medicine as, “The degree to 
which health services for individuals and populations increase the likelihood for desired 
health outcomes and are consistent with current professional knowledge” (Hughes, 
2008).  
A growing area of health services to all patients is cancer care; more and more 
Americans are being diagnosed with rare or current cancer incidences from infants to 
the geriatrics. This paper seeks to examine the impact of cancer data and show the 
point of views of those hospital registries involvements with reporting to NCDB evidence 
base reporting system within regions of Florida. 
 
Background 
 
Cancer centers are the forefront of National Cancer Institute (NCI) with support 
from universities and cancer research centers across the United States by developing 
and translating scientific knowledge from promising laboratory discoveries into new 
treatments for cancer patients (National Institutes of Health, 2013). Cancer centers are 
given the title as the institutions that are dedicated to the development of more effective 
prevention, diagnosis and treatment of cancer approaches. These organizations are run 
by physicians, nurses, administrative staff, shareholders and other ancillary professional 
but as the care is being rendered the data is being collected on each cancer incidence 
and in returned is being reported back to public as an awareness and community 
outreach.  
A cancer registry is one that has matured to be the key source of patterns and 
quality of care, care tracking and coordination and comparative effectiveness. Each 
state maintains a cancer registry, supported by the Center for Disease Control’s 
National Program of Cancer Registries. The National Cancer Institute’s Surveillance 
Epidemiology and End Results (SEER) programs ascertains more detailed information 
on patients with cancer within selected regions of the country. In reporting cases to the 
state registries and SEER it is mandated legislatively that in each report it includes all 
residents diagnosed with cancer in the state or SEER region. As reporting of cancer 
cases were conducted, within the abstract there was limited information about the 
treatment that gave limited value to study the quality of cancer care (Edge et al, 2013).  
A national system that is used among more hospital registry data is that of a 
cancer programs accredited by Commission on Cancer (CoC) of the American College 
Surgeons. Stephen Edge (2013) reported that there are 70% of patients being seen in 
hospitals for cancer treatment in which more data is being collected. CoC programs 
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have standards that they must meet in the quality of care for those initial treatments 
started at that facility. Each cancer program will report their cases on an annually basis 
to a single registry called the National Cancer Data Base (NCDB). NCDB ascertains at 
least 1 million new cases in addition to those follow up cases from each hospital 
registry. The comparison to the population registry SEER is that hospital registry 
systems present more granular treatment and continues follow up information annually. 
In the past three years CoC has developed a new quality measure mechanism 
with NCDB reporting called The Rapid Quality Reporting Systems (RQRS). CoC cancer 
program standard 5.2, for RQRS, its primary objective is to promote evidence-based 
cancer care as the key to improve the quality of care and patient outcomes 
(Commission on Cancer, 2011). To date, reporting by hospital registries are being 
conducted retrospectively and incorporating participation the RQRS it will showcase 
each registry data concurrently (Commission on Cancer, 2011). 
Purpose of Study 
In purpose of this study is to review other research evaluating the quality of 
cancer registry data. The systematic review is aim to not find the conclusion to better 
quality cancer care but is to educate others on process that has been proven to 
increase validity and reliability of data.  
Significance of Study 
Being a cancer database analyst I have taken this area to be more important to 
my studies of the field and strive to educate others within my field and those not in the 
field of health information management. Each healthcare facility that houses a cancer 
surveillance program follows the standards per ACOS but within the organization the 
team develops how they will capture the data that can be quantified as compliant.  
As the history of health information is changing from filing medical records, 
analyzing by hand to electronic storage and dissemination information cancer registries 
have stayed up to date in transitioning from record cards to cancer database software. 
By having viable software that can upload cases to be analyzed the linkage between 
ICD-9 malignant cancer codes and SNOMED pathological cases CTR abstracting time 
can be cut in half.  
Research Questions 
 This systematic review is not to prove but educate other registers to different 
process that have been an asset to increase ones treatment data valid and reliable. 
Cancer program registries collect treatment data and follow up data day to day and as 
standards for hospital-based programs there must be data collected and reported in a 
specific time frame. The CP3R was initiated in 2005 by the National Cancer Data Base 
and Commission on Cancer to supply a reporting web-based tool in collecting treatment 
retrospectively against standards to be measured. There was a time lagging gap that 
hindered treatment data to be valid, reliable and complete after 14 to 15 months 
ascertained; in 2009 The Rapid Quality Reporting System was initiated to be a faster 
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reporting tool concurrently. As this began hospital-based programs data was actively 
keeping up with standard quality measures. 
 The research question to be answered is: “How is the quality of cancer treatment data 
is being utilized for valid, reliable and complete reporting?” 
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Chapter 2 
Review of Literature 
Findings (see Table 1) Write out to reference the findings. 
Cancer Registries 
All 50 states of the United States have a cancer surveillance program which 
conducts routinely collection and compilation of identified demographic and clinical 
information of every identified malignant cancer diagnoses. The primary source for 
cancer trends over time and outcomes that can inform public health policies to act upon 
interventions to reduce cancer risks (McLaughlin, 2010).  
There are two types of cancer registries listed as hospital based and population 
based. Hospital-based registries goal attainment is to improve patient care, educate 
patient and community of cancer risk, and provide clinical trial research. In reverse, 
population-based registries set their goals with cancer prevention, cancer rates and 
trends, control efforts evaluated and to report patterns of care and outcomes per 
regions (SEER, 2014). It’s essential for the population-based system to monitor the 
state and local cancer patterns and trends but eleven years ago it would take two years 
to have completed and quality cases reported. The CDC has set standards for 
completeness, timeliness and quality as its value set at 95% completed and within six 
months date of diagnosis (Izquierdo, 2000).  
The data from cancer registries (also called tumor registries) have been over 
looked by researchers. Researchers would take the time to review medical records or 
other institutional databases to ascertain malignancies. As cancer data is being located 
on national level through the NCDB as broader use, researchers can utilize the 
information readily in a data structured view (Manasanch, 2011). Once a case is obtain 
during casefinding process a CTR must complete the abstracting within 6 months from 
initial date of diagnosis. During that time registries fail to complete an abstracted case 
due to patient not continuing care, moved out of state or treatment planned was not 
started. Even though the case might not be completed and the cancer treatment is 
noted in numerous medical records between medical specialists, the TR reflects the 
best and most accurate collection of cases by coding standards ICD9 and ICD-O for 
cancer research and care (Manasanch, 2011). 
 
Quality of Cancer Data 
 The quality of cancer care requires a suitable measure of quality with available 
use of data to apply those measures. There are three interrelated goals to the quality of 
care: surveillance, quality improvement, and accountability. Surveillance involves the 
collection to identify problems, quality improvement collects data to construct 
improvement in care and for accountability the data is collected to compare those plans, 
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groups or providers (Malin, 2002). It is a national priority to evaluate and improve the 
quality of cancer.  
The data that is store in cancer databases have key source information with 
stages and treatments that are mostly stored at hospital-based registry systems (Mallin, 
2013). Most documentation of treatment rendered is given in outpatient settings, which 
some registries might not identify all treatments in progress notes in the hospital. There 
have been studies dating back to 1990s of registries not completing the documentation 
of chemotherapy, radiation therapies by 70% of cases (Mallin, 2013). It took time and 
logistically increases in funds to seek out data on treatment not provided at the hospital. 
CTR’s or HIM analyst would have to send out yearly letters to patients and/or physician 
offices to gain access to the patient’s treatment plan and follow up. As the process of 
HIM advocacy for electronic health systems the linkage between cancer database 
systems with administrative claims and pathology reports by ICD 9 codes and SNOMED 
codes.  
Rapid Quality Reporting System  
The states are supported in part with CDC’s National Program of Cancer 
Registries; SEER program collects the more detailed information per regions of the 
country registries, as it is legislatively required to be reported. For those hospital-based 
registries under the accreditation by the CoC of the American College of Surgeons, 
programs must meet organizational and quality standards in data reported (Edge, 
2013). In the reporting those cases registries submit them annually into National Cancer 
Data Base (NCDB).  
NCDB provided tools to evaluate those patterns and survival outcomes for the 
registries then presented to public by summarizing each program resources and 
services (Edge, 2013). In 2005, the American College of Surgeons CoC had 
implemented the Cancer Program Practice Profile Reports (CP3R). CP3R was set to be 
in line with IOM objective for a nationwide reporting mechanism for those accredited 
program evidence-based consensus measuring the quality of care for breast and 
colorectal cancer (Stewart, 2011). By 2009, they were introduced into CoC program 
standards and few critiques were communicated that the reports were becoming to be 
out dated due to the ascertaining the status of treatment active.  
By 2011, RQRS was added as an extension to CP3R reporting tool as to 
expedite the data entry, programs to report concurrently than retrospective, an up-to-
date concordance rate to the state and other programs and the timing for treatment 
expectation notification tool (Stewart, 2011). This new quality of care tool mechanism 
gives an alert system to the cancer committee to ensure a timely and coordinated care 
in prompting treatment plan reviews and assure the process are in place to render the 
care (Stewart, 2011). 
 
 
 QUALITY OF CANCER REGISTRY DATA  10 
 
Chapter 3 
Methodology 
The search process to identify relevant articles conducted with an electronic 
library database. The search concluded with limited relevant article time frame of 2002 
to 2014, with search engines PubMed/MEDLINE, CINAHL (Cumulative Index to Nursing 
and Allied Health) with full text, Scopus and Google Scholar. Searching within the 
databases and search engine the used subject headings and subheadings if available 
were combined with keywords. Search terms used included cancer registry, cancer 
quality data, cancer database, electronic health systems and rapid quality review 
system, commission on cancer and cancer data.  
Selection Criteria 
 The article included if any one of the following: 
1. Validity of cancer registry data 
2. Utilization of rapid quality reporting system (RQRS) 
3. Challenges viewed as a limitation to cancer data ascertained 
The articles that were excluded in the search did not pertain to the topic but were 
reviewed before excluded. The process in selecting 14 articles (Table 2) out of 1,982 
was determined by the title and abstract description in the searches. Only selected full 
text articles were reviewed for relevance and those that were not relevant to the topic 
and criteria were excluded.  
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Chapter 4 
Results 
Validity 
The validity of cancer registry data continues to be studied among physicians 
and cancer data analyst on a daily routine. As the years pass by and the evolution of 
cancer registry, also called tumor registry, the ascertainment being conducted through 
electronic format the completed and valid key data must be reviewed for cancer 
research. Valid information on care provided is a prerequisite to accurately determining 
quality of care. Surveillance, Epidemiology, and End Results Program requires cancer 
programs to comply with a higher value ratio to show that the completeness of the 
cancer registry data for study but valid data is not as high. In 2005, National Quality 
Forum (NQF) initiated that there should be evidence-based quality measures in 
response to IOM report; with joint efforts with National Comprehensive Cancer Network 
(NCCN) and American Society of Clinical Oncology (ASCO), CoC established six 
measures for breast and colorectal cancer (Williams, 2012). The qualities measures that 
are needed to be met are scored on compliance are actively being conducted among 
cancer programs.  
In 2002, Malin and colleagues study the validity of California Cancer Registry 
data as they wanted to compare the cancer registry data to medical record data of 
breast cancer incidences. They demonstrated in the study that hospital-based registry 
data had higher score rates compared to those ambulatory medical records 
documentation of breast cancer care. Cancer patients are predominantly diagnosed at a 
hospital-based cancer facility but also can be considered first site of diagnosis at 
ambulatory sites. The listing of ambulatory sites include specialist in breast, colon, 
urology, gynecologic, hematology and dermatology that can diagnosis a cancer 
incidence but follow up care is seen mostly at hospital facilities. The lost or 
miscommunicated treatment data between these facilities can show that hospital 
registry data is much higher than if the ambulatory site would.  
Breast and colorectal cancer treatment plans were not identified up to 30% in the 
1990s due to large scales and time consuming of reviewing medical records manually. 
In a comparison the review of payer claims were used as a benchmark for complete and 
valid cancer registry treatment information from Ohio residents insured by two large 
private payers. Its finding found that through the claims data that each breast or 
colorectal case was valid and completed per surgery but a portion of 13% to 15% data 
capturing of chemotherapy or radiation therapy was not captured. Kimberly Mallin and 
colleagues discovered in her research that between the years 2004 to 2006, registries 
were not capturing those radiation and systemic therapy data that was caused a 
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magnitude of missing data but no other study was looked into why this was not being 
conducted. The change happens within cancer registries understanding and gaining 
new knowledge to gain access to those ancillary department reports (Mallin, 2013). 
The CoC and NCDB requires access to completed treatment data and by 
allowing this quality ratings have been studied with an increase in results of adjuvant 
and systemic therapies are being captured for valid and complete cancer registry data. 
The sensitivity of surgery data in research study between 1997 and 1998 improved from 
92% to 98% in 2007 and 2009; radiation improved from 74% to 88%, chemotherapy 
71% to 75% and hormonal therapy 49% to 69% (Williams, 2012). The growth has been 
somewhat improved by how cancer registries are reporting their statistics through a 
NCDB web-based auditing reporting tool called the Cancer Program Practices Profile 
Reports (CP3R) in 2005 and now has transformed over to another tool with more validity 
high ratings with the Rapid Quality Reporting System (RQRS) initiated in 2011.   
In past few years two studies conducted audits demonstrating processes that 
could impact data collection and structural data to evaluate quality cancer care. Registry 
data requires adequate steps to be reliable and if not the data can be manipulated 
easily with reported treatment data misleading performance of care (Willis, 2011). 
Besides local registries conducting audits of cancer data, regional population-based 
registries proceed with auditing the data received by outpatient facilities. In the study by 
Adele Caldarella and colleagues the data was analyzed against quality measure 
indicators, particularly structural data, retrospectively of the Tuscany region. The study 
check for compliance against the indicators and validated the results through an ad hoc 
clinical survey that did indicated homogeneity of cancer quality care statistics 
(Caldarella, 2012). Auditing registry data is very feasible to identify any variable that 
could be of poor valid and reliable data. Data entry into cancer database software can 
alert validity flag checks to auditors to complete fields that are more important for 
research and standard compliance (Willis, 2011).  
Challenges 
Cancer registries are conducted as hospital-based or on population-based and 
with many cases being reported at local hospitals the data can be challenging to collect 
what is valid and correct. As treatments are moving to more outpatient settings to 
accommodate to those patients, required reporting is raising problem. Many metrics and 
standards are to be met by registries take different methodology in acquiring the needed 
information between institutions, care settings or providers. In a report by Goldberg and 
Conti (2014) the decline of physician owned private practices in oncology was 10% 
between 2010 and 2011 that in return increased the affiliations with larger provider 
oncology groups and hospitals. As physician transition over to bigger institutions for 
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better resources, this can affect their patients to continue their care if it’s not in reach of 
their residency location.  
In 2007, American College of Surgeons’ (ACOS) Commission on Cancer (CoC) 
required steps for those accredited programs to submit all adjuvant treatment data for 
breast and colon cancer cases. The choice was targeted with these two top main 
cancer sites in requiring the data to be reported to National Cancer Database (NCDB). 
Gathering the data from outpatient settings develops a challenge with unreliable data. 
Nina Bickell et al (2013) suggested that academic medical centers only had 12% to 32% 
of radiation therapy, 8% to 29% chemotherapy and 0% to 3% hormonal treatment 
reported by local community and hospital-based oncologist. These therapies are critical 
to any quality improvement efforts as standards require cancer sites to be conducted 
with therapies in a specific time frame.  
In this study by seeking the barriers to treatment reporting the three key barriers 
were: (1) burden of manual reporting, (2) inability to identify correct managing physician, 
and (3) poor communication (Bickell, 2013). Manual abstracting occurred in tumor 
registry with time consuming to locate records, analyze the case for valid treatment 
information. As the electronic health record was implementing the timing to locate a 
record was cut down but if a certain pathology report, consult and/or surgical note were 
not uploaded it took time for the registrar to send out request letters to receive the 
needed information. Bickell et al (2013) study found that it takes a registrar average 6 
minutes per email, 5 minutes per fax, 3 minutes per letter and 8 minutes per phone call 
tracking treatment information.  
Communication is a major key with any relationship between professional setting 
and personal setting. Tumor registrars are misunderstood in their role and goals among 
community-based physicians who are aware of an existing registry (Bickell, 2013). 
When a registrar sends out request forms to complete an abstract they require the 
minimum amount of information and with those request physicians are not sure if they 
should provide all or nothing. HIPPA has been judge many times among registries and 
physician offices in that they feel they are violating the patient’s right to disseminate 
medical information. Nina Bickell qualitative assessment of these responses by 
physicians and administrative staff was seen as barrier to why the data needed was 
being depleted with those having no knowledge of the goals and role of any tumor 
registrar.  
Information technology become obsolete when newer versions are introduced 
months, years  and with many systems used in healthcare settings the communication 
among systems can be a barrier. Having the paper format of the treatment notes to be 
cumbersome it can never be easy to analyze what is needed to be pulled out to 
complete a valid cancer care reporting. IT introduced into cancer registry can help in 
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locating cancer cases with many ancillary department notes by pulling out those key 
codes and terms to be integrated to a cancer database software. As a result of this 
barrier, physician had learned to make due given the technologies they did or did not 
have in their practices (Bickell, 2013).  
Last challenge in validating cancer registry data is the connection between 
physicians and hospitals. A patient sees their primary care physician on a yearly or 
monthly for care and if there seems to be a medical care they are not specialized to 
treat they refer to that specialist. In the transition the patient is to see the specialist for 
the proper diagnosis and begin a treatment plan or surveillance. The patient may 
choose to continue the communication between the physician on the care they are 
receiving and the community-based physician expressed that the hospital-based 
physician has the best interest in communicating the needed information for their 
knowledge (Bickell, 2013). It was explained by the interviewed participant, “When I refer 
a patient to one of the full-time oncologists, I almost never get reports back and patient 
disappears” (Bickell, 2013). This is seen many times and with patients even leaving with 
no notice to the institutions and physician office the data of their treatment can be 
missed if there is no new managing physician was noted in last follow up to contact for 
the updated treatment data.  
Utilization of Rapid Quality Reporting System 
There are three national cancer registry programs. Each state maintains a cancer 
registry with support from Center for Disease Control’s National Program of Cancer 
Registries (Edge, 2013). Population-based registries report cancer incidences to the 
National Cancer Institute’s Surveillance Epidemiology and End Results (SEER), with 
more detailed information of cancer sited per select regions of the country. By reporting 
to both the state and SEER it gives a study of cancer incidence and mortality but there 
is limited amount of treatment that has higher value to each research study. As for the 
data being collected for hospital-based cancer programs is accredited by the 
Commission on Cancer (CoC) of the American College of Surgeons. The data that is 
submitted annually is reported to the National Cancer Data Base (NCDB) to aggregate 
into a single registry for research and benchmarking among facilities.  
The NCDB is used to evaluate cancer care retrospectively as there are over 
1,500 accredited programs reporting in yearly and in 2005, the CoC developed a set of 
quality measures for breast and colorectal cancer to be measured on the quality of 
registry data (Edge, 2013). In the time frame for registries to measure the standards a 
reporting, Cancer Program Practice Profile Report (CP3R) to show the performance of 
the quality measures being completed and benchmark comparison among other 
hospitals.  After four years of each registry conducting the reporting through the CP3R 
there was a delay in reporting data from 18 to 24 months after diagnosis in which Rapid 
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Quality Reporting System (RQRS) was introduced in 2009 to capture real-time clinical 
reporting. The Rapid Quality Reporting System is now being utilized among CoC 
accredited programs to concurrently collect and report data on patients, notification of 
treatment expectation in the hospital setting and exhibit up-to-date concordance rates 
compared to other hospitals at local, state and national levels (Raval et al, 2009). 
In 2011, J. David Beatty and colleagues published a report in The American 
Journal of Surgery on the CP3R based on 6 guidelines for breast and colorectal cancer 
with cancer registry data. The method look at 593 breast cases, considered to be 
analytic, among 3 databases. In their results they showed that there was compliance 
per CP3R guidelines but a high discrepancy in the characteristic of the treatment and 
tumor that resulted in inaccurate and incomplete data (Beatty et al, 2011). The 
inaccuracy of the data and quality of the care was reported in their report that with more 
cancer care provided in outpatient setting the access to those ancillary documented 
reports makes the time frame of treatment per guidelines of 4 to 5 month into 8 to 12 
month reporting (Beatty et al, 2011). J. Beatty (2011) reported, “Exploring linkage for 
synoptic pathology reports to be inserted directly into the cancer registry database, and 
evaluating the potential of electronic medical record as the primary source for data entry 
and minimize duplicate data collection.” 
In two states, Georgia and New Jersey, researchers concluded that in their 
analysis that RQRS has been shown to be a great method of identifying groups of 
patients not receiving proper care and such that a state-level cancer system could 
endorse rapid learning in adopting the real-time reporting system. Georgia researchers 
reported that state cancer plans are pervasive and hold the promise for cancer learning 
and quality improvement (Lipscomb and Gillespie, 2011). 
In September 2009, Emory University was awarded a monetary amount by the 
Association of Schools of Public Health and partnership with Center for Disease Control 
to support “Using Cancer Registry and Other Data Sources to Track Measures of Care 
in Georgia” (Lipscomb and Gillespie, 2011). The project aimed to focus on breast and 
colorectal carcinoma incidences to be linked among multiple sources that can be 
deployed for quality of care assessment. The multiple source linkage was a success in 
gathering the data but time lag behind to be in accordance with quality measures of 
treatment time frame. Building a rapid learning system to gather cancer care 
concurrently would be beneficial with the available data across administration and 
clinical data.  
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Chapter 5 
Discussion 
 The current studies in the articles reviewed processes in how cancer data is 
collected from multiple sources as the time gap between gatherings puts a decline in 
meeting quality standard measures. As the research question looking at how quality of 
cancer data can be improved, the studies were same before and after utilizing hospital-
based quality measurable tool RQRS (see Table 2). There were other studies that 
showed similarity of challenges that interfered in getting the most valid and complete 
cancer treatment data (Table 2).  
In order to have the best quality of cancer data, that is measureable to the 
standards, ascertainment must be met at its highest value among registries state, 
locally and nationally. Walker et al found in previous literature that the collection of 
adjuvant therapies were of low value but with newer process and tools implemented 
over the years the percent value has increased (Walker, 2013). Cancer programs have 
different policies and procedures in gathering the data and with IT software not being 
compatible between hospital-based and community-based practices it is not easy to 
have the data readily available to be analyzed. Bickell et al (2013) mention in their study 
that the software interfaces between the electronic medical record and tumor registry 
software can facilitate direct data transfer. As this time hospital cancer programs are 
working with oncology software in uploading cases linked to malignant carcinoma 
incidences but if that patient is not following somewhere else the data collection can be 
tough to find and time consuming to manually entering into the database.  
Another problem that hinders the quality of cancer care reported is the active 
involvement among the medical staff and administration to have the knowledge of 
knowing the goals and roles of the cancer registry. Educating those physicians on the 
importance of reporting the needed information for hospital registries can improve the 
documentation and timing of treatment conducted in outpatient setting to the quality 
standards of care.  
Future recommendations for researchers on the quality of cancer data collection 
need to re visit the challenges reexamine the participation of RQRS among hospital-
based registry systems, and if there will be other processes to identify valid cancer data. 
Another recommendation in this study is to reassess the knowledge of physician and 
administrative staff understating of the roles and objective of a cancer registry. As the 
education gap was presented in the studies, having the knowledge can lead the 
registries process to increased validity ratio and completeness of cancer incidence 
reporting in the designated time frame per standards. 
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Chapter 6 
Conclusion 
This systematic review found an ample amount of scientific literature as it related 
to the quality of cancer care and cancer registry processes. All of the published reviews 
were consistent in how the process should proceed in ascertainment of treatment data, 
educating healthcare professionals on the goals and roles within the registry field, and 
how researchers view of rapid quality reporting system is valuable. In conclusion, tumor 
registries hospital-based participation with RQRS and making the connection among 
community –based practices will greater impact cancer research, marketing and 
evidence based guidelines for cancer care.  
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